End-of-year victory for lawmakers as health care policies pass in the House; insurance limitations prompt concerns over access to semaglutide (Ozempic) for diabetes; a legal battle ensues over the fate of abortion laws in Arizona.
The House passed a significant health care package in a bipartisan 320-71 vote, marking an end-of-year accomplishment after previous setbacks, according to Stat. While the bill is unlikely to pass the Senate in its current form, the policies, including equalizing drug administration payments in Medicare across hospital outpatient departments and physician offices, addressing pharmacy benefit manager practices, and implementing health care price transparency rules, gain visibility for potential inclusion in a government funding deal. The most debated aspect, the Lower Costs, More Transparency Act, featuring site-neutral payments for drug administration, faces opposition from hospitals concerned about potential financial consequences and broader Medicare implications.
Some patients with type 2 diabetes are experiencing challenges in getting reimbursed for drugs like semaglutide (Ozempic) due to US insurers implementing restrictions to discourage prescribing the medication for weight loss, according to Reuters. Novo Nordisk acknowledged tighter health plan management of glucagon-like peptide-1 drugs, contributing to a recent decline in US prescriptions. Patients report delays and obstacles, including prior authorization requirements and the need to try alternative medications, raising concerns about potential impacts on diabetes management and overall health outcomes.
The Arizona State Supreme Court is set to hear oral arguments regarding the potential reinstatement of a centuries-old near-total abortion ban, with conflicting laws causing uncertainty after the US Supreme Court overturned Roe v Wade, according to ABC News. The current 15-week abortion ban in Arizona faces challenges, and the court will decide whether the 1864 law, which bans abortion with criminal penalties, will be enforced. Planned Parenthood Arizona aims to affirm the Court of Appeals' decision to preserve abortion access, while abortion advocates simultaneously seek a ballot measure to secure abortion rights in the state's constitution.
ICYMI: Highlights From AMCP Nexus 2024
December 26th 2024Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included relevant topics in health care policy, novel pharmaceutical developments, financial considerations across multiple conditions, and more.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Dr Yehuda Handelsman on How DCRM 2.0 Guidelines Refine CRM Disease Management
December 20th 2024In this interview, Yehuda Handelsman, MD, highlights key updates to the Diabetes, Cardiorenal, and Metabolic (DCRM) guidelines in DCRM 2.0, shaped by global collaboration and recent clinical insights.
Read More
Double Trouble: High-Deductible Plans Raise Maternity Care Costs Across 2 Calendar Years
June 27th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the June 2024 issue of The American Journal of Managed Care® about how annual high-deductible insurance plans increase maternity care costs when pregnancies cross 2 calendar years.
Listen
Year-End Spending Bill to Feature Reforms for Pharmacy Benefit Managers and Telehealth Access
December 18th 2024The health care provisions include key reforms targeting pharmacy benefit managers, extensions of Medicare telehealth flexibilities, and measures aimed at combating the opioid crisis and preparing for future pandemics.
Read More